Replies to post #5248 on GeneSYS ID Inc fka GNID

[DCorleone]

As you focus only on positive RXSF innuendo. The KEY is
"RXSF shareholders" money and what are their Fiduciary responsibilities to RXSF shareholders.
The Exaggerated marketability of this product and the protection of their investment, not common shareholders, who are financing RXSF are my POINTS, not innuendos. All my information is directly from PUBLIC INFORMATION and SEC filings of RXSF and Biometrx, with understanding your interpretation is different than mine of the ACCURATE Information.What if they had 10 million in sales not $636 last quarter after almost 6 years, what if it was a forward split instead of a Reverse of1-200..., but RXSF is being sold here as what it MIGHT BE, what it COULD be, not what it has DONE or Management has DONE since 1998. I have HISTORY to support up my opinions on what RXSF might or might not become, I don't believe in using a CRYSTAL BALL, IMO
Potential RXSF shareholders will make up their own mind on Management abilities and product Marketability.